WEST VALLEY CITY, Utah, Dec. 11, 2025 (GLOBE NEWSWIRE) — Nusano, physics company working to transform radioisotope production and enable industries ranging from healthcare to nuclear energy, today received a Best Companies to Work For award from Utah Business. Each year, Utah Business anonymously surveys thousands of individuals to identify workplaces where employees feel engaged, […]
(NASDAQ:KMTS), KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the second quarter fiscal 2026, which ended October 31, 2025. Financial Highlights Generated revenue of $22.6 million in Q2 FY26, an increase of 53% compared to the
(NasdaqGM:ORKA), MENLO PARK, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO), today announced the appointment of Chris Martin to its Board of Directors. Additionally, Cameron Turtle,
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional ADSs GlobeNewswire December 11, 2025 SAN FRANCISCO, Dec. 11, 2025 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1(TM) Phase 1b/2a Clinical Trial of TN-201 Gene Therapy MyPEAK-1 Protocol Amendments Agreed Upon with FDA; Tenaya Implementing Changes with Sites GlobeNewswire December 11, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results GlobeNewswire December 11, 2025 NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025. “We remain pleased with the progress of our pivotal Phase 3 TransportNPC(TM) study
Nusano Receives “Best Companies to Work For” Award from Utah Business State's top workplaces identified by employee survey data GlobeNewswire December 11, 2025 WEST VALLEY CITY, Utah, Dec. 11, 2025 (GLOBE NEWSWIRE) — Nusano, physics company working to transform radioisotope production and enable industries ranging from healthcare to nuclear energy, today received a Best Companies
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE(TM)-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC GlobeNewswire December 11, 2025 TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8 Clinically Meaningful Reductions
Preferred Bank Announces Dividend Increase GlobeNewswire December 11, 2025 LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today reported that the Board of Directors has increased the annual cash dividend to $3.20 per share from the previous $3.00 per share, an increase
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire December 11, 2025 WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today